<h2> </h2><div id="js_content" style="margin: 0px; padding: 0px; overflow: hidden; color: #333333; font-size: 17px; overflow-wrap: break-word; position: relative; z-index: 0; font-family: -apple-system-font, BlinkMacSystemFont, "Helvetica Neue", "PingFang SC", "Hiragino Sans GB", "Microsoft YaHei UI", "Microsoft YaHei", Arial, sans-serif; letter-spacing: 0.544px; background-color: #ffffff; visibility: visible;"><p style="padding: 0px; max-width: 100%; clear: both; min-height: 1em; box-sizing: border-box !important; overflow-wrap: break-word !important;">摘要：针对新冠肺炎轻症和普通症状的药物<strong style="margin: 0px; padding: 0px; max-width: 100%; box-sizing: border-box !important; overflow-wrap: break-word !important;">法匹拉韦</strong>，和针对重症的药物<strong style="margin: 0px; padding: 0px; max-width: 100%; box-sizing: border-box !important; overflow-wrap: break-word !important;">瑞德西韦</strong>很可能在最近分别获得日本政府和美国政府相关主管单位的批准，正式应用于治疗新冠肺炎。</p><p style="padding: 0px; max-width: 100%; clear: both; min-height: 1em; box-sizing: border-box !important; overflow-wrap: break-word !important;"><br style="margin: 0px; padding: 0px; max-width: 100%; box-sizing: border-box !important; overflow-wrap: break-word !important;" /></p><p style="padding: 0px; max-width: 100%; clear: both; min-height: 1em; box-sizing: border-box !important; overflow-wrap: break-word !important;"><img src="/EditBackyard/EditorData/Photo/2020/Mar/3192020WADE.png" width="1207" height="492" alt="" /><br /></p><p style="padding: 0px; max-width: 100%; clear: both; min-height: 1em; box-sizing: border-box !important; overflow-wrap: break-word !important;"><br style="margin: 0px; padding: 0px; max-width: 100%; box-sizing: border-box !important; overflow-wrap: break-word !important;" /></p><p style="padding: 0px; max-width: 100%; clear: both; min-height: 1em; box-sizing: border-box !important; overflow-wrap: break-word !important;"><span style="letter-spacing: 0.544px;">据美国SeekingAlpha网站报道，在纳斯达克上市的医药公司吉利德开发的药物瑞德西韦（Remdesivir）——在中国被称为“人民的希望”——可能很快会获得美国食品药物监督管理局（FDA）的正式批准。透露该消息的是投资银行</span></p><h1>Piper Sandler公司的一位分析师。</h1><p style="padding: 0px; max-width: 100%; clear: both; min-height: 1em; box-sizing: border-box !important; overflow-wrap: break-word !important;"><br style="margin: 0px; padding: 0px; max-width: 100%; box-sizing: border-box !important; overflow-wrap: break-word !important;" /></p><p style="padding: 0px; max-width: 100%; clear: both; min-height: 1em; box-sizing: border-box !important; overflow-wrap: break-word !important;">“目前我们相信瑞德西韦的临床试验的结果很可能是正面的”，分析师Tyler Van Buren如此评价吉利德公司的这一款实验性的药物。</p><p style="padding: 0px; max-width: 100%; clear: both; min-height: 1em; box-sizing: border-box !important; overflow-wrap: break-word !important;"><br style="margin: 0px; padding: 0px; max-width: 100%; box-sizing: border-box !important; overflow-wrap: break-word !important;" /></p><p style="padding: 0px; max-width: 100%; clear: both; min-height: 1em; box-sizing: border-box !important; overflow-wrap: break-word !important;">他还说：“考虑到这款药物具有安全性，如果审批顺利的话，很可能在接下来的几个月会被广泛的应用。在持续的全球疫情大流行的背景下，FDA对药效的要求会比较低。”<br style="margin: 0px; padding: 0px; max-width: 100%; box-sizing: border-box !important; overflow-wrap: break-word !important;" /></p><p style="padding: 0px; max-width: 100%; clear: both; min-height: 1em; box-sizing: border-box !important; overflow-wrap: break-word !important;"><br style="margin: 0px; padding: 0px; max-width: 100%; box-sizing: border-box !important; overflow-wrap: break-word !important;" /></p><p style="padding: 0px; max-width: 100%; clear: both; min-height: 1em; box-sizing: border-box !important; overflow-wrap: break-word !important;">虽然美股今天是两周之内的第四次熔断，但是吉利德公司的股票还是逆市大涨了6.58%，收于$79.42。道指今天暴跌了1338点，合6.3%。新能源汽车公司特斯拉的股票今天惨跌16.03%。<br style="margin: 0px; padding: 0px; max-width: 100%; box-sizing: border-box !important; overflow-wrap: break-word !important;" /></p><p style="padding: 0px; max-width: 100%; clear: both; min-height: 1em; box-sizing: border-box !important; overflow-wrap: break-word !important;"><br style="margin: 0px; padding: 0px; max-width: 100%; box-sizing: border-box !important; overflow-wrap: break-word !important;" /></p><p style="padding: 0px; max-width: 100%; clear: both; min-height: 1em; box-sizing: border-box !important; overflow-wrap: break-word !important;"><img data-backh="362" data-backw="512" data-ratio="0.70703125" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/kksjj5AteZib6dcY2vk6dmCeFulSpV30XVCqTklFEgibzU7StzHY0boIAWACCLUk216weBFYsdUdfYdibgryfsr1Q/640?wx_fmt=jpeg" data-type="jpeg" data-w="512" _width="100%" src="data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVQImWNgYGBgAAAABQABh6FO1AAAAABJRU5ErkJggg==" crossorigin="anonymous" style="margin: 0px; padding: 0px; max-width: 100%; background-color: #eeedeb; border-width: 1px; border-style: solid; border-color: #eeedeb; background-size: 22px; background-position: center center; background-repeat: no-repeat; background-image: url("data:image/gif;base64,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 overflow-wrap: break-word !important; height: 479.246px !important; width: 677px !important;" alt="" /></p><p style="padding: 0px; max-width: 100%; clear: both; min-height: 1em; box-sizing: border-box !important; overflow-wrap: break-word !important;"><br style="margin: 0px; padding: 0px; max-width: 100%; box-sizing: border-box !important; overflow-wrap: break-word !important;" /></p><p style="padding: 0px; max-width: 100%; clear: both; min-height: 1em; box-sizing: border-box !important; overflow-wrap: break-word !important;">瑞德西韦似乎不是治疗新冠病毒的唯一选项。日本媒体今天（3月18日）报道，中国医学界表示日本用于治疗新型流感病毒的药物法匹拉韦（Favipiravir）对新冠肺炎也有疗效。</p><div> </div><div><img src="/EditBackyard/EditorData/Photo/2020/Mar/3192020FARY.png" width="1207" height="492" alt="" /> </div><p style="padding: 0px; max-width: 100%; clear: both; min-height: 1em; box-sizing: border-box !important; overflow-wrap: break-word !important;"><br style="margin: 0px; padding: 0px; max-width: 100%; box-sizing: border-box !important; overflow-wrap: break-word !important;" /></p><p style="padding: 0px; max-width: 100%; clear: both; min-height: 1em; box-sizing: border-box !important; overflow-wrap: break-word !important;">中国科技部生物中心主任张新民3月17日在国务院联防联控机制新闻发布会上介绍，<strong style="margin: 0px; padding: 0px; max-width: 100%; box-sizing: border-box !important; overflow-wrap: break-word !important;">法匹拉韦已经完成了临床研究，显示出了很好的临床疗效</strong>。法匹拉韦于2014年在日本获批上市，在新冠临床研究中，未发现明显不良反应。目前，法匹拉韦被选中作为轻型、普通型向重型转化的阻断的重点药物，将尽快被纳入诊疗方案中。</p><p style="padding: 0px; max-width: 100%; clear: both; min-height: 1em; box-sizing: border-box !important; overflow-wrap: break-word !important;"><br style="margin: 0px; padding: 0px; max-width: 100%; box-sizing: border-box !important; overflow-wrap: break-word !important;" /></p><p style="padding: 0px; max-width: 100%; clear: both; min-height: 1em; box-sizing: border-box !important; overflow-wrap: break-word !important;">日本NHK电视台介绍，在深圳接受这种药物的确诊患者平均4天后转阴，而未接受该药物治疗的确诊患者平均11天转阴；经X光检查证实，使用法匹拉韦的患者，约91%的患者肺部状况有所改善，对照组这一比例为62%。</p><p style="padding: 0px; max-width: 100%; clear: both; min-height: 1em; box-sizing: border-box !important; overflow-wrap: break-word !important;"><br style="margin: 0px; padding: 0px; max-width: 100%; box-sizing: border-box !important; overflow-wrap: break-word !important;" /></p><p style="padding: 0px; max-width: 100%; clear: both; min-height: 1em; box-sizing: border-box !important; overflow-wrap: break-word !important;">不过，据日本厚生省的一位消息人士表示，<strong style="margin: 0px; padding: 0px; max-width: 100%; box-sizing: border-box !important; overflow-wrap: break-word !important;">他们认为法匹拉韦对重症和危重症患者似乎无效</strong>。</p><p style="padding: 0px; max-width: 100%; clear: both; min-height: 1em; box-sizing: border-box !important; overflow-wrap: break-word !important;"><br style="margin: 0px; padding: 0px; max-width: 100%; box-sizing: border-box !important; overflow-wrap: break-word !important;" /></p><p style="padding: 0px; max-width: 100%; clear: both; min-height: 1em; box-sizing: border-box !important; overflow-wrap: break-word !important;">日本政府可能最快于5月批准法匹拉韦对新冠患者使用的申请。<br style="margin: 0px; padding: 0px; max-width: 100%; box-sizing: border-box !important; overflow-wrap: break-word !important;" /></p><p style="padding: 0px; max-width: 100%; clear: both; min-height: 1em; box-sizing: border-box !important; overflow-wrap: break-word !important;"><br style="margin: 0px; padding: 0px; max-width: 100%; box-sizing: border-box !important; overflow-wrap: break-word !important;" /></p><p style="padding: 0px; max-width: 100%; clear: both; min-height: 1em; box-sizing: border-box !important; overflow-wrap: break-word !important;"><br style="margin: 0px; padding: 0px; max-width: 100%; box-sizing: border-box !important; overflow-wrap: break-word !important;" /></p><p style="padding: 0px; max-width: 100%; clear: both; min-height: 1em; box-sizing: border-box !important; overflow-wrap: break-word !important;"><br /></p><p style="padding: 0px; max-width: 100%; clear: both; min-height: 1em; box-sizing: border-box !important; overflow-wrap: break-word !important;">ref:</p><ol style="margin: 0px; padding: 0px 0px 0px 2.2em; max-width: 100%; box-sizing: border-box !important; overflow-wrap: break-word !important;"><li style="margin: 0px; padding: 0px; max-width: 100%; box-sizing: border-box !important; overflow-wrap: break-word !important;"><p style="padding: 0px; max-width: 100%; clear: both; min-height: 1em; box-sizing: border-box !important; overflow-wrap: break-word !important;">https://seekingalpha.com/news/3553075-gileads-covidminus-19-drug-may-get-quick-fda-approval</p></li><li style="margin: 0px; padding: 0px; max-width: 100%; box-sizing: border-box !important; overflow-wrap: break-word !important;"><p style="padding: 0px; max-width: 100%; clear: both; min-height: 1em; box-sizing: border-box !important; overflow-wrap: break-word !important;">https://www.theguardian.com/world/2020/mar/18/japanese-flu-drug-clearly-effective-in-treating-coronavirus-says-china</p></li><li style="margin: 0px; padding: 0px; max-width: 100%; box-sizing: border-box !important; overflow-wrap: break-word !important;"><p style="padding: 0px; max-width: 100%; clear: both; min-height: 1em; box-sizing: border-box !important; overflow-wrap: break-word !important;">http://www.xinhuanet.com/tech/2020-03/18/c_1125729226.htm</p></li><li style="margin: 0px; padding: 0px; max-width: 100%; box-sizing: border-box !important; overflow-wrap: break-word !important;"><p style="padding: 0px; max-width: 100%; clear: both; min-height: 1em; box-sizing: border-box !important; overflow-wrap: break-word !important;">http://www.xinhuanet.com/english/2020-03/17/c_138888437.htm</p></li></ol></div>